2-methoxy-5-((((1S)-1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)ethyl)amino)methyl)benzoic acid

We are 2-methoxy-5-((((1S)-1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)ethyl)amino)methyl)benzoic acid CAS:1391712-57-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-methoxy-5-((((1S)-1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)ethyl)amino)methyl)benzoic acid
CAS.NO:1391712-57-4
Synonyms:2-methoxy-5-((((1S)-1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)ethyl)amino)methyl)benzoic acid
2-Methoxy-5-[[[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]benzoic acid methyl ester
Methyl 2-methoxy-5-({[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)benzoate
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 600.0±55.0 °C at 760 mmHg
Molecular Formula C21H23N3O3
Molecular Weight 365.426
Flash Point 316.7±31.5 °C
Vapour Pressure 0.0±1.7 mmHg at 25°C
Index of Refraction 1.592
 
Specification:
Appearance:Off-white to light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Eluxadoline(CAS:864821-90-9).

2-methoxy-5-((((1S)-1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)ethyl)amino)methyl)benzoic acid


Related News: Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”1-(3,4-dihydro-2H-pyrrol-2-yl)ethanone The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).198904-84-6 The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).205448-66-4 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).

Related Products
Product Name
4-(6,7-dimethoxyquinolin-4-yl)oxyaniline View Details
2-Chloro-5-trifluoromethylpyridine View Details
2′,3′-Dideoxyuridine View Details
3-Amino-5-bromobenzotrifluoride manufacturer 2-BROMODIBENZOTHIOPHENE manufacturer o-Tolunitrile manufacturer 4-(Boc-amino)-1-butanol manufacturer 3-Bromo-2-chloro-5-nitropyridine manufacturer